Case File №
#VI-2026-0807
LOOKBiotech
Request Full Data Access to the VendorInvestigator database of peptide tests.
Exhibit I
Compounds on File
33 LINE ITEMS| Compound | Grade | Samples | Mean | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Tirzepatide | X Unrated | 1 | 4.7 | 4.7 | 4.7 | 25 May 2026 |
| Tesamorelin | X Unrated | 1 | 3.8 | 3.8 | 3.8 | 25 May 2026 |
| AA Water | X N/A | 1 | 4.0 | 0.0 | 0.0 | 14 Jan 2025 |
| Adipotide | X N/A | 1 | 4.0 | 1.6 | 1.6 | 20 Jun 2025 |
| AOD9604 | X N/A | 1 | 4.0 | 0.7 | 0.7 | 13 Feb 2025 |
| Blend 375 (Tren E 125mg+Mast E 125mg+Test E 125mg) | X N/A | 1 | 4.0 | 0.9 | 0.9 | 27 Feb 2025 |
| BMK ethyl glycidate CAS 41232-97-7 | X N/A | 1 | 4.0 | 0.0 | 0.0 | 17 Dec 2024 |
| BPC 500mcg + TB500 500mcg Blend Oral | X N/A | 1 | 4.0 | 0.0 | 0.0 | 3 Jul 2025 |
| Cartalax | X N/A | 1 | 4.0 | 1.6 | 1.6 | 28 Mar 2025 |
| Cerebrolysin | X N/A | 1 | 4.0 | 2.7 | 2.7 | 11 Jun 2025 |
| Crystagen | X N/A | 1 | 4.0 | 0.0 | 0.0 | 21 May 2025 |
| Drostanolone Enanthate (Mast E) Raw | X N/A | 1 | 4.0 | 0.0 | 0.0 | 2 Jul 2025 |
| GHRP-2 Acetate | X N/A | 1 | 4.0 | 0.0 | 0.0 | 3 Jul 2025 |
| GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | X N/A | 1 | 4.0 | 1.0 | 1.0 | 25 Apr 2025 |
| Gonadorelin | X N/A | 1 | 4.0 | 0.0 | 0.0 | 6 May 2025 |
| Halotestin (Fluoxymesterone) | X N/A | 1 | 4.0 | 0.7 | 0.7 | 21 May 2025 |
| Immunological Enhancement (Glutathione 200mg+Ascorbic Acid 200mg+Zinc Sulfate 2.5mg) | X N/A | 1 | 4.0 | 0.0 | 0.0 | 21 May 2025 |
| Ivermectin | X N/A | 1 | 4.0 | 1.2 | 1.2 | 13 Jun 2025 |
| Methylamine (base) CAS 74-89-5 | X N/A | 1 | 4.0 | 3.5 | 3.5 | 9 Jun 2025 |
| Orforglipron | X N/A | 1 | 4.0 | 0.0 | 0.0 | 13 Feb 2025 |
| Oxymetholone (Anadrol) Raw | X N/A | 1 | 4.0 | 3.3 | 3.3 | 27 Feb 2025 |
| P-2-P (phenyl-2-propanone / BMK) CAS 103-79-7 | X N/A | 1 | 4.0 | 0.0 | 0.0 | 8 Jul 2025 |
| Pancragen | X N/A | 1 | 4.0 | 0.2 | 0.2 | 2 Jul 2025 |
| Pinealon | X N/A | 1 | 4.0 | 0.0 | 0.0 | 24 Apr 2025 |
| Primobolan Oral (Methenolone Acetate) | X N/A | 1 | 4.0 | 0.0 | 0.0 | 17 Dec 2024 |
| Selank | X N/A | 1 | 4.0 | 0.0 | 0.0 | 20 Jun 2025 |
| Sildenafil (Viagra) | X N/A | 1 | 4.0 | 0.0 | 0.0 | 17 Dec 2024 |
| Superdrol | X N/A | 1 | 4.0 | 0.0 | 0.0 | 7 May 2025 |
| Supertest 450 | X N/A | 1 | 4.0 | 0.0 | 0.0 | 25 Apr 2025 |
| Tren Hex | X N/A | 1 | 4.0 | 1.0 | 1.0 | 21 May 2025 |
| TriTren 225 | X N/A | 1 | 4.0 | 0.0 | 0.0 | 3 Jun 2025 |
| Vilon | X N/A | 1 | 4.0 | 0.0 | 0.0 | 27 Feb 2025 |
| Winstrol Oil (Stanozolol) | X N/A | 1 | 4.0 | 0.0 | 0.0 | 14 Jan 2025 |
Exhibit II
Evidence Log
31 LABORATORY RETURNS| Filed | Compound | Score | Claimed | Found | Δ Qty | Purity | Batch № | Lab | Source |
|---|---|---|---|---|---|---|---|---|---|
| 25 May 2026 | GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | 4.1 C | 10mg | 12.2mg | +21.8% | 95.26% | 20290d | Lab B | Public |
| 24 May 2026 | Cartalax | 4.4 C | 15mg | 18.3mg | +21.7% | 97.20% | ne6vl5 | Lab F | Public |
| 24 May 2026 | Halotestin (Fluoxymesterone) | 4.0 C | 25mg | 22.3mg | -10.9% | 97.34% | e10bgh | Lab E | Public |
| 24 May 2026 | Orforglipron | 4.0 C | 100mg | 93.2mg | -6.8% | 97.64% | pk4m7e | Lab E | Public |
| 24 May 2026 | Ivermectin | 4.0 C | 10mg | 10.8mg | +7.8% | 96.06% | a26kwt | Lab D | Public |
| 24 May 2026 | Winstrol Oil (Stanozolol) | 4.0 C | 200mg/ml | 234.6mg/ml | +17.3% | 97.28% | iix208 | Lab D | Community |
| 23 May 2026 | Crystagen | 4.0 C | 15mg | 13.9mg | -7.4% | 99.46% | 1wodjn | Lab C | Community |
| 23 May 2026 | Sildenafil (Viagra) | 6.7 A | 50mg | 45.6mg | -8.8% | 99.40% | eyh9zh | Lab F | Public |
| 23 May 2026 | Vilon | 4.5 C | 50mg | 56.0mg | +12.1% | 98.76% | 6p47qt | Lab A | Public |
| 21 May 2026 | BMK ethyl glycidate CAS 41232-97-7 | 4.2 C | 5g | 4.6g | -8.2% | 97.14% | gx7qil | Lab C | Public |
| 21 May 2026 | Immunological Enhancement (Glutathione 200mg+Ascorbic Acid 200mg+Zinc Sulfate 2.5mg) | 4.0 C | 300mg/ml | 325.4mg/ml | +8.5% | 98.76% | awjr9n | Lab F | Public |
| 20 May 2026 | AA Water | 4.0 C | 10mg | 10.0mg | +0.3% | 97.33% | mg5q67 | Lab F | Public |
| 20 May 2026 | Pancragen | 4.8 C | 2mg | 2.3mg | +15.8% | 99.58% | dtpich | Lab F | Public |
| 19 May 2026 | TriTren 225 | 4.0 C | 250mg/ml | 228.9mg/ml | -8.4% | 98.28% | thxt8i | Lab D | Public |
| 26 Jan 2026 | Cerebrolysin | 4.0 C | 5mg | 5.6mg | +12.0% | 99.06% | jwy1o9 | Lab A | Public |
| 26 Jan 2026 | Tren Hex | 4.3 C | 250mg/ml | 281.3mg/ml | +12.5% | 96.64% | gkwsi8 | Lab B | Public |
| 19 Jan 2026 | Primobolan Oral (Methenolone Acetate) | 4.0 C | 10mg | 11.1mg | +11.0% | 99.23% | etgi49 | Lab B | Community |
| 9 Jan 2026 | Drostanolone Enanthate (Mast E) Raw | 5.3 B | 1g | 1.0g | +3.2% | 97.12% | id1pue | Lab B | Community |
| 7 Jan 2026 | Oxymetholone (Anadrol) Raw | 4.3 C | 5g | 6.2g | +23.2% | 97.26% | j7vylf | Lab B | Community |
| 6 Jan 2026 | AOD9604 | 4.6 C | 20mg | 19.4mg | -2.9% | 99.80% | uruf6c | Lab F | Public |
| 29 Dec 2025 | Gonadorelin | 5.6 B | 30mg | 31.9mg | +6.4% | 96.24% | 5zw326 | Lab A | Public |
| 12 Dec 2025 | Adipotide | 4.0 C | 5mg | 6.2mg | +25.0% | 99.25% | zuarjv | Lab D | Public |
| 12 Dec 2025 | Methylamine (base) CAS 74-89-5 | 5.3 B | 100g | 123.8g | +23.8% | 96.27% | d8ewdx | Lab A | Community |
| 5 Dec 2025 | Selank | 4.0 C | 2mg | 2.2mg | +10.4% | 98.01% | kbvjsq | Lab E | Community |
| 23 Nov 2025 | GHRP-2 Acetate | 6.0 A | 50mg | 51.3mg | +2.7% | 97.23% | kg6vo3 | Lab G | Public |
| 23 Nov 2025 | Pinealon | 4.0 C | 30mg | 28.2mg | -6.0% | 99.33% | qz0yod | Lab B | Community |
| 14 Nov 2025 | BPC 500mcg + TB500 500mcg Blend Oral | 5.6 B | 10mg | 9.4mg | -5.7% | 96.79% | z4g3gd | Lab F | Community |
| 14 Nov 2025 | P-2-P (phenyl-2-propanone / BMK) CAS 103-79-7 | 4.0 C | 1g | 1.2g | +19.5% | 97.13% | 6p902u | Lab B | Community |
| 14 Nov 2025 | Superdrol | 4.0 C | 20mg | 20.2mg | +1.2% | 97.21% | dm71iu | Lab D | Public |
| 3 Oct 2025 | Blend 375 (Tren E 125mg+Mast E 125mg+Test E 125mg) | 4.0 C | 100mg/ml | 96.1mg/ml | -3.9% | 96.27% | 96v2kv | Lab E | Public |
| 3 Oct 2025 | Supertest 450 | 5.0 B | 300mg/ml | 352.0mg/ml | +17.3% | 97.16% | y8x4tm | Lab C | Public |
— END OF EVIDENCE LOG —